Morphotek, Inc.-Product Pipeline Review-2016

Morphotek, Inc.-Product Pipeline Review-2016


  • Products Id :- GMDHC07986CDB
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Global Markets Direct's, 'Morphotek, Inc.-Product Pipeline Review-2016', provides an overview of the Morphotek, Inc.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Morphotek, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Morphotek, Inc.

The report provides overview of Morphotek, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Morphotek, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Morphotek, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

Evaluate Morphotek, Inc.'s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Morphotek, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Morphotek, Inc.'s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Morphotek, Inc. Snapshot 5

Morphotek, Inc. Overview 5

Key Information 5

Key Facts 5

Morphotek, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Morphotek, Inc.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Morphotek, Inc.-Pipeline Products Glance 11

Morphotek, Inc.-Clinical Stage Pipeline Products 11

Phase II Products/Combination Treatment Modalities 11

Phase I Products/Combination Treatment Modalities 12

Morphotek, Inc.-Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

Morphotek, Inc.-Drug Profiles 14

amatuximab 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

farletuzumab 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

ontuxizumab 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

KANAb-071 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

MORAb-022 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

MORAb-066 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Monoclonal Antibody Conjugates for Oncology 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

MORAb-047 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

MORAb-048 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

MORAb-050 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

MORAb-075 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Morphotek, Inc.-Pipeline Analysis 30

Morphotek, Inc.-Pipeline Products by Target 30

Morphotek, Inc.-Pipeline Products by Route of Administration 31

Morphotek, Inc.-Pipeline Products by Molecule Type 32

Morphotek, Inc.-Pipeline Products by Mechanism of Action 33

Morphotek, Inc.-Recent Pipeline Updates 34

Morphotek, Inc.-Dormant Projects 38

Morphotek, Inc.-Locations And Subsidiaries 39

Head Office 39

Appendix 40

Methodology 40

Coverage 40

Secondary Research 40

Primary Research 40

Expert Panel Validation 40

Contact Us 40

Disclaimer 41

List of Figures

Morphotek, Inc.-Pipeline by Top 10 Indication, 2016 7

Morphotek, Inc.-Pipeline by Stage of Development, 2016 9

Morphotek, Inc.-Monotherapy Products in Pipeline, 2016 10

Morphotek, Inc.-Pipeline by Top 10 Target, 2016 30

Morphotek, Inc.-Pipeline by Route of Administration, 2016 31

Morphotek, Inc.-Pipeline by Molecule Type, 2016 32

Morphotek, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2016 33

List of Tables

Morphotek, Inc., Key Information 5

Morphotek, Inc., Key Facts 5

Morphotek, Inc.-Pipeline by Indication, 2016 7

Morphotek, Inc.-Pipeline by Stage of Development, 2016 9

Morphotek, Inc.-Monotherapy Products in Pipeline, 2016 10

Morphotek, Inc.-Phase II, 2016 11

Morphotek, Inc.-Phase I, 2016 12

Morphotek, Inc.-Preclinical, 2016 13

Morphotek, Inc.-Pipeline by Target, 2016 30

Morphotek, Inc.-Pipeline by Route of Administration, 2016 31

Morphotek, Inc.-Pipeline by Molecule Type, 2016 32

Morphotek, Inc.-Pipeline Products by Mechanism of Action, 2016 33

Morphotek, Inc.-Recent Pipeline Updates, 2016 34

Morphotek, Inc.-Dormant Developmental Projects,2016 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Morphotek, Inc.; Morphotek, Inc. - Key Therapeutics; Morphotek, Inc. - Pipeline Overview and Promising Molecules; Morphotek, Inc. - News; Morphotek, Inc. - Latest Updates; Morphotek, Inc. - Pipeline; Morphotek, Inc. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 96870
Site License
USD 3000 INR 193740
Corporate User License
USD 4500 INR 290610

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com